Opinion|Articles|July 3, 2026

Nursing Leader Drives Equity in Kidney Cancer Clinical Trials

Fact checked by: Spencer Feldman
Listen
0:00 / 0:00

Key Takeaways

  • A Department of Defense–funded initiative targets underrepresented kidney cancer populations to improve clinical trial participation and address persistent disparities in access to novel therapies.
  • Leadership practices emphasize psychological safety, trust-building and dignity-centered interactions, reinforcing team cohesion and patient-family experience across high-acuity oncology settings.
SHOW MORE

Susan Rux, RN, of Fox Chase Cancer Center, leads federally funded research to expand clinical trial access for underrepresented kidney cancer patients while mentoring the next generation of oncology nurses.

With over 30 years of dedicated service in health care, Susan Rux stands as a transformative leader in oncology nursing. As the associate vice president of Professional Nursing Practice and Nursing Research at Fox Chase Cancer Center in Philadelphia, she plays a pivotal role in shaping the culture, standards and future of cancer care. Her career, spanning roles such as chief nursing officer and dean of academic affairs, reflects a lifelong commitment to elevating the practice of nursing and improving outcomes for individuals facing cancer.

At the heart of Rux's work is a profound dedication to advancing cancer research and ensuring equitable access to clinical trials. She serves as the principal investigator of a groundbreaking study focused on increasing clinical trial enrollment among underrepresented kidney cancer patients. Supported by a $564,000 Department of Defense grant, this work addresses one of the most persistent challenges in oncology: Ensuring that all patients, regardless of background, have access to innovative therapies and the hope they bring. Her research, presentations and publications have contributed meaningfully to the national dialogue on cancer disparities and the essential role of oncology nurses in bridging these gaps.

Rux is widely recognized as a culture broker and a leader who builds trust, fosters psychological safety and strengthens the human connections that define exceptional cancer care. She models compassion and respect in every interaction, honoring the inherent dignity of patients, families and colleagues. Her leadership philosophy is grounded in gratitude, humility and the belief that every team member plays a vital role in the healing process. She frequently shares personal notes of appreciation with colleagues, reinforcing a culture where people feel seen, valued and supported.

Her influence is especially evident in her commitment to developing the next generation of oncology nurses. Rux established a structured weekly check-in process for new hires and nurse residents, an approach colleagues describe as "meeting them where they are." This model ensures early support, strengthens clinical confidence and has significantly improved retention during a time of national nursing shortages. By investing in the growth of new oncology nurses, she strengthens the nursing bench and ensures that patients receive care from highly skilled, deeply supported professionals.

Rux's leadership extends far beyond her institution. She has served on numerous professional and organizational boards, including her long-standing role as a board of trustees member for the Nightingale Awards of Pennsylvania since 2008. Most recently, Rux was appointed president of the Nightingale Awards of Pennsylvania, a statewide nonprofit organization that promotes and supports careers in nursing by presenting annual nursing awards and granting scholarships to students pursuing degrees in nursing at all levels. She is a Fellow of the American College of Healthcare Executives (FACHE) and a Fellow of the New York Academy of Medicine (FNYAM), recognitions that reflect her influence across clinical, academic and administrative spheres.

In moments requiring coaching or difficult conversations, Rux leads with dignity and a focus on shared problem-solving. She ensures that colleagues participate in co-creating solutions, reinforcing their agency and professional growth. Her strategic leadership, through stretch assignments, strengthened operational partnerships and intentional recruitment, has fortified clinical operations and enhanced the patient experience at Fox Chase Cancer Center.

What truly distinguishes Rux is her unwavering commitment to the people behind the cancer journey. She understands that healing is not only clinical, but also emotional, relational and deeply human. Her work embodies the spirit of the CURE Extraordinary Healer Award: compassion in action, leadership rooted in service, and a relentless pursuit of better outcomes for patients and families facing cancer. Susan Rux is not only an exceptional oncology nurse leader, but a healer, a mentor, a visionary and a steadfast advocate for those whose lives are touched by cancer. She exemplifies the very essence of extraordinary healing.

For more news on cancer updates, research and education, don't forget to subscribe to CURE®'s newsletters here.